Hepatitis B Virus-Associated Hepatocellular Carcinoma

Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected individuals, replicating within the hepatocytes and interacting with several cellular proteins. Chronic hepatitis B can prog...

Full description

Bibliographic Details
Main Authors: Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/5/986
_version_ 1827665889783185408
author Giacomo Emanuele Maria Rizzo
Giuseppe Cabibbo
Antonio Craxì
author_facet Giacomo Emanuele Maria Rizzo
Giuseppe Cabibbo
Antonio Craxì
author_sort Giacomo Emanuele Maria Rizzo
collection DOAJ
description Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected individuals, replicating within the hepatocytes and interacting with several cellular proteins. Chronic hepatitis B can progressively lead to liver cirrhosis, which is an independent risk factor for HCC. Complications as liver decompensation or HCC impact the survival of HBV patients and concurrent HDV infection worsens the disease. The available data provide evidence that HBV infection is associated with the risk of developing HCC with or without an underlying liver cirrhosis, due to various direct and indirect mechanisms promoting hepatocarcinogenesis. The molecular profile of HBV-HCC is extensively and continuously under study, and it is the result of altered molecular pathways, which modify the microenvironment and lead to DNA damage. HBV produces the protein HBx, which has a central role in the oncogenetic process. Furthermore, the molecular profile of HBV-HCC was recently discerned from that of HDV-HCC, despite the obligatory dependence of HDV on HBV. Proper management of the underlying HBV-related liver disease is fundamental, including HCC surveillance, viral suppression, and application of adequate predictive models. When HBV-HCC occurs, liver function and HCC characteristics guide the physician among treatment strategies but always considering the viral etiology in the treatment choice.
first_indexed 2024-03-10T01:36:21Z
format Article
id doaj.art-4f22b18b8686429ab9767f4a7346dfcf
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T01:36:21Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-4f22b18b8686429ab9767f4a7346dfcf2023-11-23T13:31:23ZengMDPI AGViruses1999-49152022-05-0114598610.3390/v14050986Hepatitis B Virus-Associated Hepatocellular CarcinomaGiacomo Emanuele Maria Rizzo0Giuseppe Cabibbo1Antonio Craxì2Section of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, 90127 Palermo, ItalySection of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, 90127 Palermo, ItalySection of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, 90127 Palermo, ItalyHepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected individuals, replicating within the hepatocytes and interacting with several cellular proteins. Chronic hepatitis B can progressively lead to liver cirrhosis, which is an independent risk factor for HCC. Complications as liver decompensation or HCC impact the survival of HBV patients and concurrent HDV infection worsens the disease. The available data provide evidence that HBV infection is associated with the risk of developing HCC with or without an underlying liver cirrhosis, due to various direct and indirect mechanisms promoting hepatocarcinogenesis. The molecular profile of HBV-HCC is extensively and continuously under study, and it is the result of altered molecular pathways, which modify the microenvironment and lead to DNA damage. HBV produces the protein HBx, which has a central role in the oncogenetic process. Furthermore, the molecular profile of HBV-HCC was recently discerned from that of HDV-HCC, despite the obligatory dependence of HDV on HBV. Proper management of the underlying HBV-related liver disease is fundamental, including HCC surveillance, viral suppression, and application of adequate predictive models. When HBV-HCC occurs, liver function and HCC characteristics guide the physician among treatment strategies but always considering the viral etiology in the treatment choice.https://www.mdpi.com/1999-4915/14/5/986hepatitis B virushepatitis Bhepatitis B chronic hepatitishepatocellular carcinomahepatitis D virus
spellingShingle Giacomo Emanuele Maria Rizzo
Giuseppe Cabibbo
Antonio Craxì
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Viruses
hepatitis B virus
hepatitis B
hepatitis B chronic hepatitis
hepatocellular carcinoma
hepatitis D virus
title Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_full Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_fullStr Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_full_unstemmed Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_short Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_sort hepatitis b virus associated hepatocellular carcinoma
topic hepatitis B virus
hepatitis B
hepatitis B chronic hepatitis
hepatocellular carcinoma
hepatitis D virus
url https://www.mdpi.com/1999-4915/14/5/986
work_keys_str_mv AT giacomoemanuelemariarizzo hepatitisbvirusassociatedhepatocellularcarcinoma
AT giuseppecabibbo hepatitisbvirusassociatedhepatocellularcarcinoma
AT antoniocraxi hepatitisbvirusassociatedhepatocellularcarcinoma